-
Morphic Therapeutic (MORF) PT Lowered to $83 at BMO Capital
-
Morphic Therapeutic (MORF) Prices 3.5M Share Upsized Common Offering at $70/Sh
-
Morphic Therapeutic Announces Pricing of Upsized $245.0 Million Public Offering
-
Morphic Therapeutic Announces Pricing of Upsized $245.0 Million Public Offering
-
Morphic Therapeutic (MORF) Announces $200M Proposed Public Offering of Common Stock
-
Morphic Therapeutic Announces Proposed Public Offering
-
Morphic Therapeutic Announces Proposed Public Offering
-
Morphic Therapeutic (MORF) PT Raised to 'Street High' $111 at BMO Capital
-
Morphic Therapeutic (MORF) PT Raised to $40 at BMO Capital
-
Morphic Therapeutic (MORF) PT Raised to $37 at BMO Capital, Following Earnings
-
Morphic Therapeutic (MORF) PT Raised to $32 at BMO Capital
-
BMO Capital Starts Morphic Therapeutic (MORF) at Outperform
-
Morphic Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Morphic Holding, Inc. (MORF) Prices 6M Share Upsized IPO at $15/Sh
-
Morphic Announces Pricing of Upsized Initial Public Offering

